After long negotiations MEPs agreed on the EU’s pharmaceutical reform. It includes longer exclusivity for data filed to get marketing approval for new drugs. But pharma still isn’t happy

The creation of the European Health Data Space is in the balance, with talks between the Parliament and Council set to continue on Thursday, in a bid to agree a deal before the EU elections

Clinical research backed by the EU is bringing life-saving medicines and health tools to sub-Saharan Africa. This success story offers a valuable lesson as negotiations get underway on the next research programme

Europe is home to some of the world’s most innovative food companies creating alternative proteins, but many are choosing to launch their products first in the US or Singapore

A COVID-19 testing laboratory that is surplus to requirements has been put up for sale by the UK government. Like other redundant research facilities before it, there is now an opportunity to build the local life sciences ecosystem

Phages that kill bacteria are seen as a possible solution to the waning power of antibiotics. But research funding is lacking and existing routes to approval and commercialisation are not suitable for these therapies, say UK MPs

Trilogue negotiations are underway on the European Health Data Space, which will enable cross-border sharing of data, including for research. Standardisation will be key to the plan’s success

The independent advice panel is at the centre of a transparency row after its report on pharmaceutical innovation was withdrawn, prompting MEPs to challenge its leadership

It is promised as the most important update for more than twenty years, but tensions are high as MEPs struggle to reach a compromise over the EU’s proposed pharmaceutical reform